SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-23-044791
Filing Date
2023-02-22
Accepted
2023-02-22 16:03:10
Documents
2
Group Members
GUY LEVYSOLEUS CAPITAL GROUP, LLCSOLEUS CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G d470128dsc13g.htm SC 13G 94474
2 EX-99.A d470128dex99a.htm EX-99.A 9221
  Complete submission text file 0001193125-23-044791.txt   105275
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Subject) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59985 | Film No.: 23653012
SIC: 2834 Pharmaceutical Preparations

Mailing Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830
Business Address 104 FIELD POINT ROAD 2ND FLOOR GREENWICH CT 06830 4752083111
Soleus Capital Master Fund, L.P. (Filed by) CIK: 0001812275 (see all company filings)

IRS No.: 981413657 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G